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Abstract
Background: Clinical practice guidelines (CPGs) are formally developed statements that assist users to provide
proper health care for a kind of disease and play a significant contribution in healthcare system. This study report
the methodological quality of CPGs on constipation.
Methods: The “Appraisal of Guidelines and Research and Evaluation” (AGREEII) instrument was developed to
determine the quality of CPGs. A comprehensive search was developed using five databases and three
guideline websites until/up to December, 2015. Four independent authors evaluated the methodological
issues of the CPGs by the AGREEII instrument.
Results: We identified 22 relevant guidelines on constipation from 1234 citations. The overall agreement
among evaluators was 0.84 using the intra-class correlation coefficient. The mean AGREEII scores for the
domains “scope and purpose” (51.77) and “rigor of development” (56.73) were moderate; afterward, three
domains “stakeholder involvement” (32.23), “editorial independence” (29.59) and “applicability” (29.14) were
low scores. The “clarity and presentation” (23.73) had the lowest scores.
Conclusion: Although existing constipation guidelines may accurately reflect current clinical practices, many
guidelines’ methodological quality is low. Therefore, more emphasis and attentions should be taken to the
development of high-quality guidelines.
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Background
Constipation is a disorder defined by incomplete
defecation, and/or infrequent bowel movements which
associated with persistent difficult and/or painful
defecation, fecal incontinence, and abdominal pain [1]. It
is a common clinical functional diseases. The worldwide
constipation surveys show a wide range of prevalence
rates between 1 % and >20 % in western populations,
although, a recent epidemiological reports found 16 %
general adult populations were constipation [2]. Consti-
pation may be found for up to 20 % of community-
dwelling elderly individuals. Moreover the incidence of
functional constipation in childhood estimated 3 % [3].
Because of its high disease burden, the treatment of
constipation has become an important issue for clini-
cians and patients. During the last two decade there
were more than 20 developed clinical practice guide-
lines (CPGs) to manage the constipation. The main
role of the CPGs is to give clear recommendations to
help clinicians make appropriate clinical decision for
specific clinical circumstance [4, 5].
However, not all guidelines are developed with the
same methodologically rigorous approaches, there is no
research for evaluating the quality of CPGs on constipa-
tion so far. With the above in mind, the objectives of the
present study was to systematically review guidelines
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using the appraisal of guidelines for research and evalu-
ation (AGREEII) instrument related to constipation [6].
Methods
Literature search
An electronic literature search using multiple databases
(PubMed, EMBASE, The China Journal Full-text Data-
base, Chinese Biomedical Literature Database, Chinese
Scientific Journals Full-text Database), and guideline
website or databases—including the Guidelines Inter-
national Network (GIN) Database, the National Guide-
line Clearinghouse (NGC), National Institute for Health
and Care Excellence (NICE), Scottish Intercollegiate
Guidelines Network (SIGN), National Comprehensive
Cancer Network (NCCN) was conducted limited to
Chinese and English from the inception to May 2015.
MeSH terms and text words “guideline, consensus, rec-
ommendation, criteria, statement, constipation” for con-
stipation and guidelines were used within the MEDLINE
database. The same search strategy was made applicable
for the other databases or websites.
Guideline selection and data extraction
Four reviewers (THL,DC,LN,GJF) independently ex-
tracted the guidelines which met the characteristics (for
example, a clear guideline definition as proposed by the
institute of Medicine [4], focused exclusively on consti-
pation disease). We constructed a standard form table to
extract the data of guidelines. Four reviewers extracted
data separately, disagreements were discussed or by a
fifth reviewer (GXL) if no consensus was reached.
Quality appraisal and recommendation
We evaluated the twenty-two included CPGs quality by
AGREEII instrument [6]. The instrument includes a 23-
item tool comprising six quality domains. The four au-
thors read the entire AGREEII handbook and then inde-
pendently rated all included guidelines using formula as
follows:
Obtained score ‐ Minimum possible score
Maximum possible socre ‐ Minimum possible score
 100%
According to the handbook for use of the AGREEII in-
strument, the six domain scores were considered inde-
pendently. Finally, a guideline is labelled as “strongly
recommended” if most domain scores are greater than
60 %. Guideline is “recommended” when most scores
are between 30 % and 60 %. A guideline is labelled as
“not recommended” when most domain scores are less
than 30 % [7].
Statistical analysis
A descriptive study of item frequency was carried out
and the AGREEII domain scores calculated as means.
Intra-class correlation coefficients (ICCs) is a measure of
the reliability of measurements or ratings within each
domain [8]. Statistically significant was considered if p
value less than 0.05.
Results and discussion
Literature search
Figure 1 shows how we screened the guidelines, we
preliminary search found 1234 citations, 35 were
excluded because they were duplicate citations. By
screening their titles and abstracts and 1,146 citations
were ineligible as they didn’t meet the characteristics
of constipation CPGs, 31 articles were excluded from
the left 53 studies as following: eight were duplicates,
seven were not in English or Chinese, 14 were guide-
lines not related to constipation, and 2 guidelines
were the old version. Finally, a total of 22 guidelines
were included [9–31].
Guideline characteristics
The summary of CPGs baseline data were shown in
Table 1. The twenty-two CPGs published between 2000
and 2014. Of the 22 selected CPGs, half of were from
north America (America and Canada), six from European
(UK, Ireland, Italy, Sweden) and the remaining five were
from Asia (two from China, one from Korea, one from
Indonesia and one multi-national),respectively. The scope
of the CPRs varied: one guideline topic covered prevention,
diagnosis and treatment of constipation [31]; two focused
only on prevention and treatment [14, 16]; 16 covered
diagnosis and treatment [9, 12, 13, 15, 17–19, 21–29]; three
only focused on treatment [10, 20, 30] and one focused on
prevention [11]. CPGs cited a range of number of refer-
ences (range: 0–364, mean: 78) and were of varying length
(mean number of pages = 25, range: 5–255). Each of the
domains being evaluated using the AGREEII appraisal
(Table 2). The ICCs score was moderate among raters
(0.84; 95 % CI, 0.56–0.86).
Appraisal of guidelines
Domain 1
Scope and purpose is concerned with the overall aim of
the guideline, the specific health questions, and the tar-
get population (items 1–3) [32]. This domain’s mean
score was 51.77 %, and nine of the guidelines (47.62 %)
scored below 50 % [9, 10, 12, 21, 22, 25, 26, 29, 31].
Domain 2
Stakeholder involvement focuses on the extent to
which the guideline was developed by the appropri-
ate stakeholders and represents the views of its
intended users (items 4–6) [32]. Of all AGREEII do-
mains, this domain received the lowest scores
(23.73 %) with only one CPG scoring over 50 %.
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Eighteen CPGs had been developed by a multi-
disciplinary organization (81.82 %) [9, 11, 13–30].
Domain 3
Rigor of development criteria relates to the process used
to gather and synthesize the evidence, the methods to
formulate the recommendations, and to update those
(items 7–14) [32]. Overall, the mean score for this do-
main was only 32.23 % (range, 3 % to 66 %), with 18
CPGs scoring < 50 %. Meanwhile, only five CPGs re-
ported systematic evidence searching [12, 16, 18, 27, 30],
and Just 40.90 %(9/22) guidelines provided the methods
for formulating the recommendations [11–16, 26, 27, 29].
Moreover, an explicit link between the recommendations
and the evidence were explicit in 20/22 of the guidelines
and only five guidelines described a procedure about up-
dating [11, 13, 21, 27, 29].
Domain 4
Clarity of presentation deals with the language, struc-
ture, and format of the guideline (items 15–17) [32].
The mean score for this domain was 56.73 % (range,
36 % to 83 %). Most CPGs provided a concrete and
precise description of key recommendations with only
eight guidelines scoring less than 50 % [9, 10, 14, 22,
25, 26, 30, 31].
Domain 5
Applicability pertains to the likely barriers and facili-
tators to implementation, strategies to improve up-
take, and resource implications of applying the
guideline (items 18–21) [32]. This domain’s score was
29.14 % (range, 10 % to 58 %) and only three CPGs
scored > 50 % [11, 18, 20]. A total of 10 CPGs discussed
barriers to implementing the guideline’s recommendations
[11, 13, 14, 16, 18, 20, 21, 29–31] and 7 guideline provides
advice and/or tools on how the recommendations can
be put into practice [11, 16, 18, 20, 29–31]. Resource
implications were not explicitly discussed, only five
CPGs offered cost implications [11, 18, 20, 29, 30].
Domain 6
Editorial independence is concerned with the formula-
tion of recommendations not being unduly biased with
competing interests (items 22–23) [32]. The mean score
for this domain was 29.59 %. Fifteen guidelines scored
PubMed: n = 651,
EMBASE: n = 359.
Chinese Databases: n=152 
(WANFANG, CBM, CNKI)
Guideline Website: n=72 
(NICE, GIN, SIGN, WHO, NGC, 
NCCN)
1234 potentially relevant papers 
identified and screened
1199 potentially relevant papers 
screened by titles and abstracts
53 full-texts retrieved and assessed
22 guidelines included
31 papers were excluded:
Duplicates: n = 8,
Not English or Chinese: n = 7,
The practice guidelines just mention or not 
related to constipation: n = 14,
The full-text version not available: n = 2.
1146 papers were excluded:
Not practice guideline: n =996, 
Interpretation of practice guideline: n = 9,
Translation of practice guideline: n = 16,
The practice guidelines not related to 
constipation: n = 125.
35 duplicates excluded 
between those databases
Fig. 1 Flow of information through the different phases of the literature search
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Table 1 Characteristics of clinical practice guidelines for constipation
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Table 1 Characteristics of clinical practice guidelines for constipation (Continued)
American Gastroenterological
Association Medical Position
Statement on Constipation [29]




































Footnotes: NICE National Institute for Health and Care Excellence, ESMO European Society for Medical Oncology, ESDO European Society of Digestive Oncology, NCCN National Comprehensive Cancer Network, SEOM
Spanish Society of Medical Oncology, GIN Guidelines International Network, NASPGHAN North American Society for Pediatric Gastroenterology, Hepatology and Nutrition, AIGO Italian Association of Hospital
Gastroenterologists, SICCR Italian Society of Colo-Rectal Surgery, NCC-WCH National Collaborating Centre for Women‘s and Children‘s Health, KSNM Constipation Study Group in the Korean Society of Neurogastroenter-
ology and Motility, NASPGHAN the North American Society for Pediatric Gastroenterology Hepatology and Nutrition, ESPGHAN: the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition, ANMA the
Asian Neurogastroenterology and Motility Association, AGA American Gastroenterological Association, RNAOPA Registered Nurses Assocation of Ontario-Professional Association, ONS the Oncology Nursing Society, ISG
The Indonesian Society of Gastroenterology, CACM China Association of Chinese Medicine, WGO World Gastroenterology Organization, CMAG/CMAS Chinese Medical Association of Gastroenterology Branch, Chinese












Table 2 Guideline score according to score on each of the domains assessed by the AGREEII instrument
Title Scope and
Purpose







31 % 11 % 7 % 44 % 15 % 0 % Not recommended
Practice Guidelines for the
Management of Constipation
in adults [10]
44 % 22 % 36 % 44 % 25 % 0 % Not recommended
Prevention of constipation in
the older adult population [11]
81 % 39 % 58 % 72 % 54 % 54 % Strongly recommended
Management of chronic
constipation: recommendations
from a consensus panel [12]
39 % 14 % 9 % 53 % 17 % 33 % Not recommended
Evaluation and Treatment of
Constipation in Infants and
Children: Recommendations
of the North American Society
for Pediatric Gastroenterology,
Hepatology and Nutrition [13]
56 % 31 % 46 % 58 % 31 % 0 % Recommended
Putting evidence into practice:
evidence-based inventions for
the prevention and management
of constipation in patients with
cancer [14]
64 % 28 % 45 % 47 % 33 % 0 % Recommended
The management of constipation
in palliative care: clinical practice
recommendations [15]
56 % 17 % 41 % 67 % 23 % 21 % Not recommended
Management of constipation [16] 75 % 31 % 63 % 67 % 44 % 29 % Recommended
National Consensus on The
Management of Constipation in
Indonesia 2010 [17]
56 % 8 % 3 % 69 % 10 % 0 % Not recommended
Constipation in Children and
Young People: Diagnosis and
Management of Idiopathic
Childhood Constipation in
Primary and Secondary Care [18]
78 % 61 % 50 % 75 % 54 % 71 % Strongly recommended
Consensus Recommendations for
the Management of Constipation
in Patients with Advanced,
Progressive Illness [19]
50 % 19 % 40 % 64 % 21 % 50 % Recommended
Prucalopride for the treatment
of chronic constipation in
women [20]
56 % 39 % 33 % 72 % 58 % 50 % Recommended
Common views on diagnosis
and treatment of chronic
constipation with Chinese
medicine [21]





36 % 14 % 14 % 47 % 21 % 83 % Not recommended
Consensus statement AIGO/SICCR
diagnosis and treatment of
chronic constipation and
obstructed defecation [23, 24]
50 % 19 % 48 % 50 % 21 % 17 % Not recommended
Practical Treatments for
Constipation in Korea [25]
44 % 11 % 16 % 39 % 21 % 33 % Not recommended
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below 50 %. Most (63.64 %) guidelines did not provide
the information whether they received funding or not
[9–11, 13, 14, 16–18, 20–22, 25, 26, 29].
Overall assessment
Guidelines were graded by the overall assessment. Only
two CPGs can be strongly recommended [11, 18]. Eight
can be recommended with provisions or alterations be-
cause of the most domains scoring between 30 % and
60 % [13, 14, 16, 19, 20, 27, 28, 30]. The remaining 12
CPGs were labelled as ‘not recommended’ due to the
poor domain scores [9, 10, 12, 15, 17, 21–26, 31]
(Table 2).
Stratification of CPG quality
In order to examine which factors may have impacted
quality scores in the six domains, we stratified the
data on the following variables (guideline area,
AGREEII publication date, publication type, working
group, comprehensive search or not, fund support or
not, and evidence-based or not) in Table 3. We didn’t
find the difference in six domains quality related to
publication year of AGREEII (before or after 2010).
Meanwhile, guidelines published in guideline data-
bases were significantly have a higher scores than that
in journals. The scores from CPGs developed by med-
ical societies were higher when compared with indi-
viduals for the following items: Scope &Purpose,
Stakeholders, Rigour, and Applicability. If CPGs were
evidence-based, those three domains (Rigour, Applic-
ability and Editorial independence) would have a
higher scores. Apart from above, we found no differ-
ences in the rest of the comparisons.
Discussion
We conducted a comprehensive assessment of the qual-
ity of CPGs for constipation. In general, these guidelines
existed many deficits. Most of the guidelines had a low
score in the following (domain 2, domain 3, domain 5
and domain 6). Table 4 showed that the scores results
when compared with international CPGs level [33].
According to the results, the mean score of domain 3
received only 32.23 %. Methods of the search and the
criteria for choose evidence must be clearly described.
Meanwhile, the contents of health benefits and risks, ex-
ternally reviewed by experts should be provided. In
order to improve the score of domain 3, particular atten-
tion should be paid in above shortcomings.
There were only 2 CPGs included guideline devel-
oping experts in the panel [11, 18]. What’s more, no
patients was invited to participate in the development
term. The domain 5 “applicability” have an important
role in the CPGs promotion, it should provide advice
and/or tools on how the recommendations can be put
into practice. These low scores reflect that CPG pro-
ducers remain have much work to be done to im-
prove guideline applicability.
Lastly, the scores in the domain 6 were less than 30 %.
Many guidelines are developed with external funding,
the name of the funding body and a statement that the
funding body did not influence the content of the guide-
line should be explicit consideration [34]. What’s more,
Table 2 Guideline score according to score on each of the domains assessed by the AGREEII instrument (Continued)
Diagnosis and Treatment
Guideline of Chronic
Constipation in China [26]
25 % 11 % 15 % 47 % 19 % 0 % Not recommended
Evaluation and Treatment of
Functional Constipation in
Infants and Children: Evidence-
Based Recommendations From
ESPGHAN and NASPGHAN [27]
81 % 25 % 66 % 83 % 23 % 38 % Recommended
Primary Care Management of
Chronic Constipation in Asia:
The ANMA Chronic
Constipation Tool [28]
50 % 36 % 22 % 53 % 23 % 38 % Recommended
American Gastroenterological
Association Medical Position
Statement on Constipation [29]
33 % 17 % 25 % 61 % 42 % 25 % Not recommended
Lubiprostone for treating chronic
idiopathic constipation [30]




consensus statement on opioid-
induced constipation [31]
42 % 22 % 15 % 36 % 25 % 42 % Not recommended
Total (X±SD) 51.77 ± 18.24 23.73 ± 13.16 32.23 ± 19.24 56.73 ± 12.91 29.14 ± 13.55 29.59 ± 25.91 -
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there should be a clearly declaration that competing in-
terests of guideline development group members have
been recorded and addressed. Therefore, conflict of in-
terests need to be clearly stated.
There are two guidelines which we want to recommend
strongly due to their high overall quality developed by
Registered Nurses Association of Ontario-Professional
Association (RNAOPA) [11] and an Italian guideline by
the National Collaborating Centre for Women‘s and
Children‘s Health (NCC-WCH) [18]. The detailed recom-
mendations were listed in Table 5. Eight of twenty-two
guidelines can be reported with provisos and alterations
[13, 14, 16, 19, 20, 27, 28, 30], while the remaining 12
CPGs could not be recommended because most domain
scores below 30 % [9, 10, 12, 15, 17, 21–26, 29–31].
However, our evaluation has several limitations.
First, AGREEII rarely suggest how guidelines should
select topics. To be useful, guidelines should address
the challenges that clinicians face in practice, but de-
velopers may exclude clinically important topics
when available evidence does not meet minimum
standards. Second, inclusion criteria have a language
restriction (English and Chinese), language search
bias might happen. Third, we used only the AGREEII
instrument evaluated the CPGs other than instru-
ments may bring some selection bias [35]. AGREEII
instrument have been introduced from 2010, frankly
speaking, guidelines published before 2010 did not
have access to AGREEII to comply with it. Unfortu-
nately, there is no difference when we compare the











Constipation mean scores 52 24 32 57 29 30
International mean scores 64 35 43 60 22 30
Table 3 Mean (±SD) AGREEII scores by subgroups
Subgroups Scope & Purpose Stakeholders Rigour Clarity Applicability Editorial Independence
Year of publication
≤ 2010 (n = 12) 57.17 ± 15.41 26.67 ± 14.93 35.92 ± 19.77 61.00 ± 11.4 32.08 ± 16.62 25.67 ± 25.98
> 2010 (n = 10) 45.30 ± 20.18 20.20 ± 10.53 27.80 ± 18.80 51.60 ± 13.34 25.67 ± 25.98 34.30 ± 26.39
P values 0.146 0.249 0.337 0.096 0.247 0.451
Publication Type
Journal (n = 16) 44.72 ± 15.14 18.33 ± 7.88 25.72 ± 17.65 53.94 ± 12.35 24.17 ± 8.30 24.83 ± 22.83
Database (n = 6) 68.17 + 14.74 38.5 + 12.93 47.67 + 11.84 62.33 + 14.43 45.5 + 12.49 45.17 + 26.63
P values 0.003 0.01 0.004 0.239 0.007 0.134
Type of development group
Individual (n = 4) 50.00 ± 16.79 22.25 ± 6.95 30.75 ± 24.42 50.00 ± 13.29 27.75 ± 11.47 26.00 ± 18.17
Medical society (n = 18) 52.17 ± 19.07 24.06 ± 14.39 32.59 ± 18.85 58.22 ± 12.74 29.44 ± 14.17 30.39 ± 27.70
P values 0.829 0.718 0.896 0.318 0.808 0.707
Systematic search
No (n = 14) 47.57 ± 16.55 19.79 ± 10.70 29.50 ± 17.86 55.43 ± 11.51 26.79 ± 113.64 22.00 ± 27.5
Yes (n = 8) 59.13 + 20.01 30.63 + 15.07 37.00 + 22.5 59.00 + 15.70 33.25 + 13.02 42.88 + 17.03
P values 0.190 0.1 0.428 0.585 0.288 0.04
Financial
No (n = 14) 46.08 ± 15.97 19.23 ± 9.74 25.31 ± 18.73 52.31 ± 10.78 23.77 ± 8.63 15.08 ± 17.59
Yes (n = 8) 60.00 ± 19.21 30.22 ± 15.39 42.22 ± 16.22 63.11 ± 13.68 36.89 ± 15.85 50.56 ± 21.48
P values 0.46 0.97 0.51 0.91 0.10 0.18
Evidence-based
No (n = 13) 46.08 ± 15.97 19.23 ± 9.74 25.31 ± 18.73 52.31 ± 10.78 23.77 ± 8.63 15.08 ± 17.59
Yes (n = 9) 60.00 ± 19.20 30.22 ± 15.39 42.22 ± 16.22 63.11 ± 13.68 36.89 ± 15.85 50.56 ± 21.48
P values 0.09 0.08 0.04 0.07 0.04 0.00
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six domains quality before and after 2010. We can
find even if methodological requirements for CPGs
are reported comply with these remains unsatisfac-
tory. What’s more, how to spread the CPGs preferable
is essential for clinical practice [36]. Through above
specific methodological quality analysis, which can ef-
fectively promote the development of future constipa-
tion CPGs.
Conclusions
The results find that the quality of CPGs for constipa-
tion is poor. Guideline quality may be improved if we
comply with the AGREEII instrument.
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